Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Aspira Women’s Health ( (AWHL) ) has shared an update.
On September 16, 2025, Aspira Women’s Health Inc. entered into securities purchase agreements with investors, resulting in a private placement of common stock and warrants, raising approximately $2.95 million. The company plans to use these funds for working capital and general corporate purposes. This financial move, along with an additional $112,500 from warrant exercises, provides Aspira with a total equity capital infusion of $3.06 million. This capital will support Aspira’s ongoing commercial activities and growth plans, as the company focuses on executing its strategic goals and expanding its innovative product pipeline in women’s health diagnostics.
The most recent analyst rating on (AWHL) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Aspira Women’s Health stock, see the AWHL Stock Forecast page.
Spark’s Take on AWHL Stock
According to Spark, TipRanks’ AI Analyst, AWHL is a Neutral.
The company’s challenging financial position, marked by unprofitability and negative equity, significantly impacts its stock score. While technical indicators show some positive momentum, the lack of profitability and adverse corporate events weigh heavily on the overall assessment.
To see Spark’s full report on AWHL stock, click here.
More about Aspira Women’s Health
Aspira Women’s Health Inc. is a company focused on the discovery, development, and commercialization of noninvasive, AI-powered tests for diagnosing gynecologic diseases. Their products, such as OvaWatch® and Ova1Plus®, are part of the OvaSuiteSM, which offers blood tests to help detect ovarian cancer risk in women with adnexal masses. Aspira is also developing tests for endometriosis, aiming to enhance diagnostic capabilities using microRNA and protein biomarkers.
Average Trading Volume: 101,602
Technical Sentiment Signal: Sell
Current Market Cap: $14.8M
For an in-depth examination of AWHL stock, go to TipRanks’ Overview page.